Track the Sai Life Sciences Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Sai Life Sciences Limited has logged 1 insider filings. Market capitalisation: €279.2bn. The latest transaction was filed on 21 February 2025 (Sale). Among the most active insiders: TUNER GHOSH. The full history is free.
Analysts rate Sai Life Sciences Limited Strong Buy (bullish), based on 6 analysts. Average price target: ₹1,275.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Sai Life Sciences Limited is a company focused on the healthcare and pharmaceutical sector, providing research and development solutions as well as manufacturing services. It is listed on the XBOM market.